The effects of HIF-2α in CIN and treatment groups were demonstrated by using the modified CIN protocol of Sun et al. [17], with biochemical parameters, histopathological analyses, and immunohistochemical tests. This evidence concerns the gene EPAS1 and cervical squamous intraepithelial neoplasia.